September 18, 2018 – from 8.30 to 13.30
Carassa-Dadda” Great Hall
Politecnico di Milano – via Raffaela Lambruschini, 4 20156 Milano
The fourth industrial revolution is in full swing and is deeply involving health care models, directing them towards digital transformation.
In medicine, the use of Artificial Intelligence (AI) is allowing a change of approach aimed at achieving unprecedented customization and precision in treatments, therapies and administration of drugs, as well as in the use of biomedical devices. When we talk about the use of AI in the study of new therapeutic approaches, we think about how this can simplify the complexity of research projects and the development of new products. To understand the potential of AI in the specific field of clinical research, a group of experts will analyze in an interactive symposium the impact and benefits that it will be able to bring in this specific field of medicine.
Who is it aimed at?
The event is aimed at managers of the pharmaceutical industry, medical devices and health professionals working in the field of research and clinical trials.
Agenda
8.30 Welcome and introduction to the event
What impact will AI have on clinical research and experimentation in the next 3 years?
Massimo Beccaria – Managing Director Alfa Technologies International
Giuseppe Recchia – Vice President Medical Scientific, GSK
8.55 What do we mean by IA…
everything you wanted to know and never dared ask.
Matteo Matteucci – Associate Professor at Politecnico di Milano Lecturer in Robotics, Cognitive Robotics, and Machine Learning
9.20 We use Intelligence in the use of AI.
Roberto Fantino – President of NAT Style
9.45 New fields of application of the IA in research and health.
Enrico G. Caiani – Associate Professor at Politecnico di Milano, Chairman of WG e-Cardiology European Society of Cardiology, Professor of eHealth and Bioengineering
10.10 Coffee Break
10.25 Decision Support Technologies and Clinical Research Assistants.
Gorgio Manfredi – CEO Rumbletumbleweed, CEO Occambee, Founder Forever Identity Inc., ISMC Advisor
10.50 AI integrated in medical devices, practical applications.
Maurizio Viviani – CEO Strong Artificial Intelligence, San Francisco
11.15 Implementing business processes with Cognitive Computing
Strategic roadmap for the adoption of IA in the pharmaceutical sector
Ettore Murciano – VP Channel Sales and Alliances, Loop AI Labs Inc. San Francisco
11.40 The IA at the service of clinical trials and medical research
Eugenio Santoro – Head of the Medical Informatics Laboratory, Mario Negri Institute for Pharmacological Research – IRCCS
12.15 New technologies for research, when to innovate.
Sergio Scaccabarozzi – Head of Country Clinical Operations-Italy, Roche
12.40 Round table and discussion with the rapporteurs
13.30 Conclusions
Source link: https://lsacademy.com/it/corsi/intelligenza-artificiale-e-ricerca-clinica/
To register, please fill in the following form